Dermata Therapeutics (DRMA) Prepaid Assets (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Prepaid Assets of $427279.0 for Q1 2026, up 105.2% year-over-year from $208228.0 in Q1 2025, and up 24.99% quarter-over-quarter from $341848.0 in Q4 2025.
Dermata Therapeutics (DRMA) Prepaid Assets (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $427279.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 105.2% year-over-year to $427279.0; the TTM figure through Mar 2026 stood at $427279.0 (up 105.2% YoY), while the FY2025 annual figure was $341848.0, down 2.28% from the prior year.
- Prepaid Assets for Q1 2026 stood at $427279.0, up from $341848.0 in the prior quarter.
- The five-year high for Prepaid Assets was $908067.0 in Q3 2022, with the low at $45826.0 in Q3 2025.
- The 5-year median for Prepaid Assets is $427279.0 (2026), against an average of $453509.8.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets tumbled 91.57% in 2025, then jumped 105.2% in 2026.
- Dermata Therapeutics' Prepaid Assets stood at $703194.0 in 2022, then fell by 23.14% to $540499.0 in 2023, then plunged by 35.28% to $349824.0 in 2024, then slipped by 2.28% to $341848.0 in 2025, then rose by 24.99% to $427279.0 in 2026.
- Business Quant data shows DRMA's Prepaid Assets at $427279.0 in Q1 2026, $341848.0 in Q4 2025, and $45826.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 427,279.00 |
| Dec 31, 2025 | 341,848.00 |
| Sep 30, 2025 | 45,826.00 |
| Jun 30, 2025 | 159,586.00 |
| Mar 31, 2025 | 208,228.00 |
| Dec 31, 2024 | 349,824.00 |
| Sep 30, 2024 | 543,592.00 |
| Jun 30, 2024 | 289,452.00 |
| Mar 31, 2024 | 446,075.00 |
| Dec 31, 2023 | 540,499.00 |
| Sep 30, 2023 | 691,900.00 |
| Jun 30, 2023 | 274,351.00 |
| Mar 31, 2023 | 528,346.00 |
| Dec 31, 2022 | 703,194.00 |
| Sep 30, 2022 | 908,067.00 |
| Jun 30, 2022 | 398,543.00 |
| Mar 31, 2022 | 853,057.00 |
| Dec 31, 2021 | 825,134.00 |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 709,662.00 |